• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Anesthetizing solution and its method of application for the anesthetized, stunning and killing of fish. This invention relates to an anesthetizing solution comprising a natural anesthetic agent (clove essential oil, isoeugenol and/or eugenol), nanoencapsulated in β -cyclodextrins, forming an inclusion complex, wherein the proportion of the natural anesthetic in the complex of inclusion is between 5 and 30% and the proportion of beta-cyclodextrins between 70 and 95% of the total mass of the complex, in which the anesthetizing agent is formulated in fresh water, seawater, liquid ice or water with crushed ice, in a concentration between 5 and 60 mg/kg. Also contemplated are the methods developed for anesthetizing, stunned and/or sacrificing fish based on the use of the solution of the invention. (Machine-translation by Google Translate, not legally binding)
    公开号:ES2576077A1
    申请号:ES201630258
    申请日:2016-03-04
    公开日:2016-07-05
    发明作者:Alfonsa GARCÍA AYALA；Amanda Esperanza LÓPEZ CÁNOVAS；Antonio López Gómez；Victoriano Francisco MULERO MÉNDEZ；María ROS CHUMILLAS
    申请人:Universidad Politecnica de Cartagena；
    IPC主号:
    专利说明:

    image 1
    image2
    image3
    image4
    image5


    The formation of inclusion complexes between cyclodextrins and different molecules is widely studied in the literature. In this way, it is possible to change the behavior of these molecules, getting for example that they are more water soluble. The cyclodextrins constitute a group of natural cyclic oligosaccharides derived from starch with six, seven or eight glucose molecules linked by glycosidic bonds α (1-4) forming a cylindrical structure, called α, β and -cyclodextrins, respectively . The central cavity of these molecules is hydrophobic, while the outer edges of the walls surrounding this cavity are hydrophilic. This hydrophobic cavity forms inclusion complexes with a wide range of organic type host molecules. As established by Marques' work (Marques HMC (2010). A review on cyclodextrin encapsulation of essential oils and volatiles. Flavor and Fragrance Journal, 25 (5): 313-326), cyclodextrins can be considered as nanoencapsulation agents and the formation of the cyclodextrin-host complex is equivalent to a molecular encapsulation, since the host molecules are isolated from each other and dispersed at the molecular level in an oligosaccharide matrix.
    Also, inclusion complexes of essential oils can be formed with cyclodextrins (Marques 2010). For example, the work of Hernández-Sánchez et al (Hernández-Sánchez P., López-Miranda S., Lucas-Abellán C., Núñez-Delicado E. (2012). Complexation of Eugenol (EG), as Main Component of Clove Oil and as Pure Compound, with β-and HP-β-CDs. Food and Nutrition Sciences, 3: 716-723), studies the molecular association between β-CD and eugenol and clove essential oil, although it does not study its application in the anesthesia of fish.
    The authors of the present invention, in light of the needs of the state of the art in relation to the problems derived from anesthesiating, stunning and fish slaughter, have developed a new formulation based on the use of nanoencapsulated natural anesthetics in β-cyclodextrins . The inclusion complexes thus formed are formulated with water and / or ice, giving rise, surprisingly, to solutions with a very low anesthetic agent concentration, compared to those employed in the prior art, and equally effective. These solutions, applied to the anesthetized, stunned and slaughtered fish of aquaculture or experimentation, thus provide very significant advantages over the state of the art, since, in addition to decreasing the amount of anesthetizing agent, and therefore the unwanted effects derived from same, allows
    7
    image6


    with crushed ice, or liquid ice, for anesthesiating, stunning and slaughter of aquaculture and experimental fish, such as, for example, sea bream, sea bass, trout, salmon and zebrafish.
    In a main embodiment of the invention an anesthesia solution (hereinafter solution of the invention) comprising a natural anesthetic agent nanoencapsulated in β-cyclodextrins, forming an inclusion complex is contemplated. The proportion of the natural anesthetic in the inclusion complex is between 5 and 30%, of the total mass of the complex, preferably between 10 and 20%, and the proportion of β-cyclodextrins in the inclusion complex is between 70 and 95% of the total mass of the complex, preferably between 80 and 90%.
    The anesthetizing agent is formulated in fresh water, in seawater, in liquid ice (defined as liquid ice as set forth in the article by Kauffeld, M., Wang, MJ, Goldstein, V., Kasza, KE (2010). Ice slurry applications, International Journal of Refrigeration, 33 (8), 1491-1505, where it is referred to in English as “ice slurry”), or in water with crushed ice, in a concentration between 5 and 60 mg / kg, preferably between 10 and 40 mg / kg, depending on the water temperature (concentrations equivalent to mg of anesthetic agent per kg of initial water).
    The natural anesthetic agent used in the solution of the invention is an essential oil, in particular clove essential oil, and / or the components thereof, such as eugenol and isoeugenol.
    The β-cyclodextrins used for the anesthetic formulation object of this invention should be for food use, listed as a food additive called E-459. They must have the appearance of white powder, odorless, and must have a minimum purity of 98% (anhydrous base), a moisture content not exceeding 14% (determined by the Karl Fischer method), and a content of other cyclodextrins not exceeding 2% (on an anhydrous basis). Your solution in water should be colorless.
    The nanoencapsulation of the essential oil in β-cyclodextrins can be carried out by any of the following methods used in the state of the art: kneading method, co-precipitation method (based or not based on solubility of
    9
    image7
    image8
    image9
    image10


    significantly higher values in fish stunned with crushed ice and seawater (1: 1), when compared with those individuals stunned with the anesthetist at concentrations of 20 and 40 mg / l, and at room temperature.
    With regard to blood pCO2 values (mmHg) (Figure 3), differences in mean values obtained for those stunned fish with AEC + β-CD concentrations of 40 mg / L and in liquid ice were observed. -5 ° C, if compared with the traditional stunning and slaughter procedure, using crushed ice in seawater (1: 1) without AEC (Treatment C).
    When comparing the glucose levels (ng / mL) in serum of each of the gilthead individuals (Figure 4 A), with treatment with AEC + β-CD at different concentrations with seawater at room temperature (28-29 ° C) ), no significant differences were observed between them (Figure 4 A). However, a certain tendency to increase the glucose level was observed by increasing the applied dose of anesthesia (198.25 ng / mL to 20 mg / L of clove oil; 226 ng / mL to 40 mg / L of oil from clove; and 318.5 ng / mL at 60 mg / L of clove oil). In any case, the level of blood glucose in the sea bream is always lower when the anesthesia solution used in this patent is used, when compared with the stunned sea water with crushed ice (1: 1). Therefore, and in this case, when the stunning of sea bream in seawater at room temperature is carried out, it is proposed to use the lowest concentration of AEC + β-CD (20 mg / L). This would be a method of interest in the anesthesia of aquaculture or experimentation fish when they do not want to be slaughtered. On the other hand, there are significant differences between individuals stunned with liquid ice at -5 ° C (Figure 4 B) with and without AEC + β-CD, and fish stunned with crushed ice and seawater (1: 1) without AEC + β-CD. Fish stunned with liquid ice with AEC + β-CD suffer less stress than those stunned in seawater and crushed ice (1: 1).
    In these exemplary embodiments of the invention, significantly higher levels of lactate, pCO2, HCO3 and glucose were observed in gilthead specimens stunned with seawater and crushed ice (1: 1) compared to those stunned with the anesthetic based on AEC included in β-CD in liquid ice at -5 ° C, or at room temperature. The lower values of these parameters, which are indicators of fish stress during stunning, correspond to the fact that when stunning and slaughter technology is used
    14


    object of this patent, on gilthead aquaculture, stunning times of 10-15 s (in liquid ice with AEC + β-CD), or less than 55 seconds (in seawater with crushed ice, with AEC + β) are achieved -CD), compared to times of more than 4 minutes obtained with sea water and crushed ice (1: 1) without AEC + β-CD (which is the traditional method of stunning and
    5 slaughter in aquaculture).
    In studies by other authors (such as that of Lerfall et al 2015) similar results of stress have been obtained when the stunned is done with sea water and crushed ice. These authors verified that the levels of metabolites in plasma and tissues are altered by stress induced in salmon slaughtered with seawater and crushed ice (1: 1), which translates, for example, into a significant increase in blood glucose levels, and in higher levels of blood lactate. Also, the effects of stress observed by Lerfall et al (2015) in salmon relate induced hypercapnia to high levels of pCO2 and HCO3 in stunned and sacrificed specimens with the traditional method of
    15 stunned and sacrifice using seawater and crushed ice.
    With these examples of implementation of the formulation and methods of application of the new natural anesthetic solution, object of this patent, it is demonstrated that much lower stunning times (from 10 to 55 seconds) are achieved compared to the method
    20 traditional current used in aquaculture (water with crushed ice, in a 1: 1 proportion by weight). Therefore, this natural anesthetic solution and its method of application for stunning and fish slaughter also results in less suffering and less stress in the fish, so it also contributes to a significant improvement in animal welfare.
    fifteen
    权利要求:
    Claims (1)
    [1]
    image 1
    image2
    类似技术:
    公开号 | 公开日 | 专利标题
    Moon et al.1995|Hypertonic saline-dextran resuscitation from hemorrhagic shock induces transient mixed acidosis
    Weber et al.2008|Xenon induces late cardiac preconditioning in vivo: a role for cyclooxygenase 2?
    Haitsma et al.2004|Surfactant therapy for acute lung injury/acute respiratory distress syndrome
    Konia et al.2009|Nuclear factor-κB inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning
    BRPI0510449A|2007-10-30|use of meloxicam formulations in veterinary medicine
    Rosário et al.2011|SvO2-guided resuscitation for experimental septic shock: effects of fluid infusion and dobutamine on hemodynamics, inflammatory response, and cardiovascular oxidative stress
    BR112016007509B1|2020-12-01|anhydrous antiperspirant composition comprising alcl3 or any hydrates thereof, method of preventing or reducing sweating and method of preparing the anhydrous antiperspirant composition
    Corrêa et al.2016|Balanced crystalloids for septic shock resuscitation
    Saleemi et al.2009|Pathological effects of gentamicin administered intramuscularly to day-old broiler chicks
    ES2576077A1|2016-07-05|Anesthetizing solution and its method of application for the anesthetized, stunning and killing of fish |
    Tao et al.2015|Hydrogen-rich saline attenuates lipopolysaccharide-induced heart dysfunction by restoring fatty acid oxidation in rats by mitigating C-Jun N-terminal kinase activation
    Huang et al.2018|Remote ischemic postconditioning improves myocardial dysfunction via the risk and safe pathways in a rat model of severe hemorrhagic shock
    Fekete et al.2013|Myocardial postconditioning is lost in vascular nitrate tolerance
    Campos et al.2017|Effect of free and nanoencapsulated copaiba oil on monocrotaline-induced pulmonary arterial hypertension
    Yin et al.2016|Thioredoxin protects skin flaps from ischemia-reperfusion injury: A novel prognostic and therapeutic target
    Okusa et al.2009|Acute memory phase of sevoflurane preconditioning is associated with sustained translocation of protein kinase C-α and ε, but not δ, in isolated guinea pig hearts
    CL2017002306A1|2018-03-23|Stable formulation for parenteral administration of tapentadol
    da Luz et al.2015|Myocardial protection induced by fentanyl in pigs exposed to high‐dose adrenaline
    Yilmaz et al.2006|Intravenous administration of choline or CDP-choline improves platelet count and platelet closure times in endotoxin-treated dogs
    Soares et al.2017|Arrhythmias in leptospirosis-associated acute kidney injury: a case series
    RU2019137020A|2021-01-14|REDUCED OXIDATION COMPOSITIONS
    AR056017A1|2007-09-12|ANIMAL VACCINE FORMULATIONS, METHOD FOR PREPARING A VACCINE FORMULATION AND VACCINE STABILIZING COMPONENT
    Varga et al.2014|A novel method for in vivo visualization of the microcirculation of the mandibular periosteum in rats
    EA202190798A1|2021-09-10|ROTAMERIC ISOMERS OF 4-ALKYL-5-HETEROARYL-3H-1,2-DITHIOL-3-THIONES
    Ibarra-Lara et al.2015|PPARα Stimulation Modulates Myocardial Ischemia-induced Activation of Renin–Angiotensin System
    同族专利:
    公开号 | 公开日
    EP3424536A4|2019-09-11|
    WO2017149179A1|2017-09-08|
    EP3424536B1|2021-01-27|
    ES2576077B1|2017-03-24|
    EP3424536A1|2019-01-09|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    ES2613240A1|2017-03-09|2017-05-23|Universidad Politécnica De Cartagena|Ice composition with antimicrobial activity, manufacturing method and applications thereof. |NZ244531A|1992-09-28|1996-05-28|Nz Inst For Crop & Food Res|Anaesthetising, sedating or euthanising marine animals using a solution of eugenol or isoeugenol|
    AU7942498A|1997-06-04|1998-12-21|Aqui-S Limited|Compositions and methods for sedating, anaesthetising and euthanising aquatic organisms|
    AUPQ633900A0|2000-03-20|2000-04-15|Jurox Pty Ltd|Anaesthetic composition|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    ES201630258A|ES2576077B1|2016-03-04|2016-03-04|Anesthesia solution and its method of application for anesthesia, stunning and fish slaughter|ES201630258A| ES2576077B1|2016-03-04|2016-03-04|Anesthesia solution and its method of application for anesthesia, stunning and fish slaughter|
    EP17759312.6A| EP3424536B1|2016-03-04|2017-02-27|Anaesthetic solution and method of use thereof for anaesthetising, stunning and slaughtering fish|
    PCT/ES2017/070108| WO2017149179A1|2016-03-04|2017-02-27|Anaesthetic solution and method of use thereof for anaesthetising, stunning and slaughtering fish|
    [返回顶部]